aTyr Pharma Inc
NASDAQ:ATYR

Watchlist Manager
aTyr Pharma Inc Logo
aTyr Pharma Inc
NASDAQ:ATYR
Watchlist
Price: 3.97 USD -0.5% Market Closed
Market Cap: 333.2m USD

aTyr Pharma Inc
Investor Relations

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel immunological pathways. The company is headquartered in San Diego, California and currently employs 49 full-time employees. The company went IPO on 2015-05-07. Its therapeutic candidate pipeline includes efzofitimod (ATYR1923), ATYR2810, NRP2 mAbs, AARS-1 and DARS-1. The ATYR1923, is a fusion protein comprised of the immunomodulatory domain of histidyl-tRNA synthetase fused to the fragment crystallizable (Fc) region of a human antibody and serves as a selective modulator of NRP2 that downregulates innate and adaptive immune response in inflammatory disease states. The firm is also developing efzofitimod as a potential disease-modifying therapy for patients with fibrotic lung diseases with high unmet medical need. ATYR2810 is a fully humanized monoclonal antibody that specifically and functionally blocks the interaction between NRP2 and one of its primary ligands VEGF. ATYR2810 is in preclinical development for the potential treatment of certain aggressive cancers where NRP2 is implicated.

Show more
Loading
ATYR
S&P 500
1Y 3Y 5Y 10Y 15Y 20Y

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Sanjay S. Shukla M.D., M.S.
President, CEO & Director
No Bio Available
Ms. Jill M. Broadfoot CPA
Chief Financial Officer
No Bio Available
Ms. Nancy E. Denyes Krueger J.D.
General Counsel & Corporate Secretary
No Bio Available
Xiang-Lei Yang Ph.D.
Founder
No Bio Available
Dr. Jayant Aphale MBA, Ph.D.
Vice President of Technical Operations
No Bio Available
Ms. Ashlee Dunston
Director of Investor Relations & Corporate Communications
No Bio Available
Mr. Peter Villiger
Vice President of Corporate Development
No Bio Available
Ms. Danielle Campbell
VP of Human Resource
No Bio Available
Dr. Leslie Nangle Ph.D.
Vice President of Research
No Bio Available
Dr. Ying J. Buechler Ph.D.
Executive Director of Biologics Development & Manufacturing
No Bio Available

Contacts

Address
CALIFORNIA
San Diego
3545 John Hopkins Ct Ste 250
Contacts
+18587318389.0
www.atyrpharma.com
sparklesyt

See Also

Summary
ATYR intrinsic value, competitors valuation, and company profile.
DCF Valuation
ATYR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ATYR stock valuation using valuation multiples.
Wall Street Estimates
ATYR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ATYR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 238,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.